华润医药(03320.HK) 与纳米及先进材料研发院(NAMI)今天(14日)签署合作框架协议,双方将携手推进“Palbociclib在阿兹海默病治疗中的纳米传递优化”项目,并由香港大学支援药效研究,致力应对阿兹海默病这一全球医疗领域的挑战。全球目前有逾5,000万名患者罹患阿兹海默病,随着全球老龄化加剧,预计患者数量将持续攀升,长远为医疗系统带来沉重负担。通过结合NAMI的新型药物输送系统和...
Source Link华润医药(03320.HK) 与纳米及先进材料研发院(NAMI)今天(14日)签署合作框架协议,双方将携手推进“Palbociclib在阿兹海默病治疗中的纳米传递优化”项目,并由香港大学支援药效研究,致力应对阿兹海默病这一全球医疗领域的挑战。全球目前有逾5,000万名患者罹患阿兹海默病,随着全球老龄化加剧,预计患者数量将持续攀升,长远为医疗系统带来沉重负担。通过结合NAMI的新型药物输送系统和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.